These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30971416)

  • 1. EBM verdict: should albendazole be used for treating lymphatic filariasis? No.
    Onakpoya IJ
    BMJ Evid Based Med; 2019 Aug; 24(4):141-142. PubMed ID: 30971416
    [No Abstract]   [Full Text] [Related]  

  • 2. Albendazole for lymphatic filariasis.
    Addiss D; Critchley J; Ejere H; Garner P; Gelband H; Gamble C;
    Cochrane Database Syst Rev; 2004; (1):CD003753. PubMed ID: 14974034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of lymphatic filariasis.
    Michael E; Malecela-Lazaro MN; Kazura JW
    Lancet; 2006 Jul; 368(9533):362-3; author reply 363-4. PubMed ID: 16876654
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphatic filariasis.
    Wkly Epidemiol Rec; 2003 May; 78(20):171-9. PubMed ID: 12808788
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for the use of albendazole for the elimination of lymphatic filariasis.
    Sunish IP; Rajendran R; Mani TR; Dash AP; Tyagi BK
    Lancet Infect Dis; 2006 Mar; 6(3):125-6. PubMed ID: 16500593
    [No Abstract]   [Full Text] [Related]  

  • 6. Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000.
    McLaughlin SI; Radday J; Michel MC; Addiss DG; Beach MJ; Lammie PJ; Lammie J; Rheingans R; Lafontant J
    Am J Trop Med Hyg; 2003 May; 68(5):568-73. PubMed ID: 12812348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass drug administration to treat lymphatic filariasis.
    Ravindran B
    Lancet; 2002 Jun; 359(9321):1948. PubMed ID: 12057582
    [No Abstract]   [Full Text] [Related]  

  • 8. Elimination of transmission of lymphatic filariasis in Egypt.
    Molyneux DH
    Lancet; 2006 Mar; 367(9515):966-8. PubMed ID: 16564345
    [No Abstract]   [Full Text] [Related]  

  • 9. The development of albendazole for lymphatic filariasis.
    Horton J
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S33-40. PubMed ID: 19843396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
    Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL
    Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albendazole for lymphatic filariasis.
    Critchley J; Addiss D; Gamble C; Garner P; Gelband H; Ejere H;
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003753. PubMed ID: 16235339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphatic filariasis].
    Sante; 2000; 10(5):360-1. PubMed ID: 11221698
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphatic filariasis and Brugia timori: prospects for elimination.
    Fischer P; Supali T; Maizels RM
    Trends Parasitol; 2004 Aug; 20(8):351-5. PubMed ID: 15246315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustainability of soil-transmitted helminth control following a single-dose co-administration of albendazole and diethylcarbamazine.
    Rajendran R; Mani TR; Munirathinam A; Sunish IP; Abdullah SM; Augustin DJ; Satyanarayana K
    Trans R Soc Trop Med Hyg; 2003; 97(3):355-9. PubMed ID: 15228259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of parasite drug resistance in human lymphatic filariasis.
    Cobo F
    Rev Esp Quimioter; 2016 Dec; 29(6):288-295. PubMed ID: 27858056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community empowerment in the control of lymphatic filariasis in Misima, Milne Bay Province using diethylcarbamazine in combination with albendazole.
    Selve BP; Bwadua S; Misa M; James K; Usurup JP; Turner P; Melrose W; Yad W; Samuel R; Eddie C
    P N G Med J; 2000; 43(3-4):183-7. PubMed ID: 11939299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifilarial drugs, in the doses employed in mass drug administrations by the Global Programme to Eliminate Lymphatic Filariasis, reverse lymphatic pathology in children with Brugia malayi infection.
    Shenoy RK; Suma TK; Kumaraswami V; Rahmah N; Dhananjayan G; Padma S
    Ann Trop Med Parasitol; 2009 Apr; 103(3):235-47. PubMed ID: 19341538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment.
    Supali T; Djuardi Y; Pfarr KM; Wibowo H; Taylor MJ; Hoerauf A; Houwing-Duistermaat JJ; Yazdanbakhsh M; Sartono E
    Clin Infect Dis; 2008 May; 46(9):1385-93. PubMed ID: 18419441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection.
    Khan AM
    Indian J Med Res; 2018 Jan; 147(1):7-10. PubMed ID: 29749354
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphatic filariasis elimination programme in India: progress and challenges.
    Ramaiah KD
    Trends Parasitol; 2009 Jan; 25(1):7-8. PubMed ID: 19008150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.